 |
2′-deoxycytidine |
|---|---|
| Trade Name | |
| Orphan Indication | As a host-protective agent in the treatment of acute myelogenous leukemia |
| USA Market Approval | USA |
| USA Designation Date | 1996-09-09 00:00:00 |
| Sponsor | Grant, Steven M.D.;Massey Cancer Center, VCU, P.O. Box 980230;Richmond, Virginia, 23298 |
